Skip to content
Screener

Inspire Medical Systems INSP Investing Cash Flow

Investing Cash Flow at other companies

ResMed logo
ResMedRMD
-$383.65M-187%
LivaNova logo
LivaNovaLIVN
-$31.92M-256%
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
-$12.65M-78.2%
Neuropace, Inc. logo
Neuropace, Inc.NPCE
-$117K-216%
ClearPoint Neuro logo
ClearPoint NeuroCLPT
-$645K-252%
Globus Medical logo
Globus MedicalGMED
-$129.05M+56.9%

Other financials

Income statement

See full
Revenue$204.6M+1.6%
Gross profit$176.9M+3.7%
Operating income-$1.1M+24.7%
Net income-$11.3M-477%
EPS (diluted)-$0.39-490%

Balance sheet

See full
Cash & equivalents$98.9M+83.6%
Total debt$29.6M-11.8%
Total equity$792.3M+24.6%
Total assets$911.4M+24.7%

Cash flow

See full
Operating cash flow$12.8M+292%
CapEx$9.7M+15.7%
Free cash flow$3.1M+121%

Valuation

See full
Market cap$1.7B-26.6%
Enterprise value$1.63B-27.3%
P/E13×-30.7×
P/S1.9×-0.8×

Profitability

See full
Gross margin85.8%+1.1pp
Operating margin5.6%-0.3pp
Net margin14.3%+6.4pp
FCF margin10.6%+1.2pp

Returns & leverage

See full
Return on equity18.4%+7.5pp
Debt / equity0.0×
Current ratio6.3×-2.7×

Where this comes from

Reported directly by Inspire Medical Systems in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.

The source filing: Inspire Medical Systems’s 10-Q, filed May 4, 2026.

Filed
May 4, 2026, 4:07 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001609550-26-000023
Line itemThree Months Ended March 31, 2026Three Months Ended March 31, 2025
Capital expenditures(9,726)(8,407)
Purchases of investments(57,312)(17,319)
Proceeds from sales or maturities of investments55,78924,173
Net cash (used in) investing activities(11,249)(1,553)
Financing activities
Proceeds from the exercise of stock options1096,441
Share repurchase of common stock(75,009)
Payment of taxes on net share settlement of equity awards(7,591)(19,192)

Item 1. Financial Statements.

FAQ

What is Inspire Medical Systems's investing cash flow?
Inspire Medical Systems (INSP) reported investing cash flow of -$11.25M in Q1 2026.
How has Inspire Medical Systems's investing cash flow changed year-over-year?
Inspire Medical Systems's investing cash flow decreased by 624.3% year-over-year, from -$1.55M to -$11.25M.
What does investing cash flow mean?
Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.

Ask your AI about Inspire Medical Systems's investing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude